Cannabis Reclassification May Open Banking Door for Dispensaries

President Donald Trump’s executive order to reclassify cannabis from a Schedule I controlled substance to Schedule III is poised to open the doors of the U.S. banking system for licensed dispensaries, analysts say. The shift is anticipated to make cannabis banking tech viable for businesses that have long operated in a cash‑only, shadow realm—ushering in electronic payments, larger credit lines, and a path to federal compliance.

Background: A Decade‑Long Banking Lockout

Since the Controlled Substances Act of 1970 placed marijuana among the most restricted drugs—alongside heroin and LSD—federal authorities have treated any cannabis transaction as proceeds of a crime. The result is a fragmented financial landscape for a market that exploded into an estimated $30 billion retail revenue stream in 2024.

Under the current Schedule I status, payment processors and banks either refuse service outright or require cumbersome compliance measures that create a financial exile for dispensaries. Without access to credit or debit card processing, companies like Elad Kohen’s The Flowery, which runs 26 stores across Florida and New York and employs 600 people, must hand customers cash or gift cards, exposing staff to theft and limiting transparency for auditors and regulators.

Meanwhile, the legal cannabis industry employs more than 400,000 workers and operates nearly 15,000 licensed dispensaries, yet remains an outlier in the mainstream banking system because of legal uncertainty, collateral valuation challenges, and the high cost of Suspicious Activity Reports (SARs) that banks must file for every cannabis transaction.

Key Developments: Trump’s Fast‑Track Reclassification

In a groundbreaking move, President Trump has directed the Justice Department to fast‑track cannabis reclassification. The order, signed on December 24, 2025, will reclassify marijuana as Schedule III, placing it alongside regulated pharmaceuticals such as anabolic steroids and Tylenol with codeine.

By moving to Schedule III, cannabis gains a recognized medical status that is “consistent with the therapeutic potentials and safety profiles” of other Schedule III drugs. The primary objective of the reclassification plan is to “increase medical marijuana and CBD research,” but industry observers argue the change will have a cascading effect on banking, credit, and taxation.

• Payment Processing: With a new schedule, payment processors can view cannabis sales as legitimate transactions, enabling electronic card processing and reducing the security risk associated with handling cash.
• Banking Access: Traditional banks will view cannabis businesses as standard commercial entities, making it easier to offer commercial loans, merchant accounts, and other financial services.
• Tax Treatment: Schedule III status will bring cannabis under the same federal tax framework as other industries, potentially unlocking tax credits and deductions that are currently denied to marijuana businesses.

The reclassification also aligns with the growing demand for cannabis research. According to the White House briefing, the fast‑track plan is expected to “open a floodgate” for scientific study, catalyzing further investments and innovation in the sector.

Impact Analysis: What This Means for Dispensaries and Consumers

For dispensaries, the most immediate benefit is the ability to process credit and debit card payments. This eliminates the constant “cash‑only” narrative, provides a paper trail that boosts credibility, and reduces staff exposure to theft. As Elad Kohen notes, “You’re dealing with paper, which makes you a target for crime.” A system that integrates cannabis banking tech would protect employees, streamline operations, and improve the overall customer experience.

Financial access is another major upside. With banks willing to offer credit lines and equipment financing, dispensaries can invest in inventory management systems, refrigeration upgrades, and technology platforms that enhance compliance and traceability—essential for meeting state and federal audit requirements.

International students and researchers interested in the cannabis industry can see new hiring opportunities and internships in finance, technology, and compliance roles at dispensaries and ancillary service providers. Banks that previously shied away from the market will likely open new advisory desks for cannabis clients, creating a demand for professionals well‑versed in both financial regulation and the unique dynamics of the cannabis sector.

Consumers stand to benefit from lower costs as supply chain efficiencies increase. Electronic payments reduce handling fees, while better inventory management can curb product shortages and price volatility. Additionally, higher capital access can fund research that may lead to safer and more effective cannabis products.

Expert Insights: Navigating the New Financial Landscape

Dr. Amiyatosh Purnanandam, a finance professor at the McCombs School of Business, argues that reclassification will lower the three major barriers that have kept banks away: legal uncertainty, collateral valuation, and suspicious activity reporting. “Once cannabis is treated like a normal company, the risk profile for lenders drops substantially,” he says.

Peter Su, a cannabis banking consultant, points out that banks will still need to perform “intensive, ongoing monitoring” after reclassification. He emphasizes that compliance will be far more rigorous than for typical retail accounts. “The question is not whether banks can serve cannabis, but how efficiently and safely they can do so,” Su explains.

Kohen remains optimistic: “We are not asking for anything special other than being treated like a normal company, having the ability to raise capital like a normal company, be able to fund research like a normal company, and have financial services available to us like a normal company.” The reclassification, he argues, is a pivotal step toward that goal.

Looking Ahead: From Schedule III to Market Integration

While the executive order marks a significant milestone, the path to full integration will require additional legislative and regulatory actions. Congress must address the lingering state‑federal legal conflicts, and the Treasury will need to establish clear guidelines for cannabis banks.

Tax policy remains a gray area. Although Schedule III status removes certain prohibitions, a Senate bill introduced by Oklahoma Republican Sen. James Lankford would bar tax deductions and credits for cannabis businesses. The outcome of that and potential bipartisan tax reforms will shape the industry’s long‑term economic viability.

In the coming months, banks are likely to pilot cannabis banking tech solutions, partnering with fintech firms to develop secure, compliant payment platforms. These pilot programs will create benchmarks for risk assessment, data security, and regulatory reporting that could set industry standards for years to come.

For international students and professionals, the evolving landscape opens avenues in fintech, compliance law, and financial technology. Universities and research institutions may partner with cannabis companies to develop curricula that blend business, technology, and legal studies, positioning graduates at the forefront of this emerging field.

Ultimately, reclassification to Schedule III is seen as the beginning of a broader cultural shift. By erasing the stigma that has long tied cannabis to illicit markets, it promises to democratize access to capital, accelerate research, and bring the industry into the mainstream economy.

Reach out to us for personalized consultation based on your specific requirements.